Watanabe A, Higashi T, Sakata T, Nagashima H
Cancer. 1984 Nov 1;54(9):1875-82. doi: 10.1002/1097-0142(19841101)54:9<1875::aid-cncr2820540918>3.0.co;2-o.
Serum amino acid concentrations in cirrhotic patients with and without hepatocellular carcinoma (HCC) were investigated. Elevation of serum aromatic amino acids (AAA) and methionine levels observed in cirrhotic patients without malignancy was not apparent in cirrhotic cases with HCC, and thus the ratio of branched chain amino acids (BCAA) to AAA was not so diminished in the latter cases. Development of hepatic encephalopathy in cirrhotic patients with HCC led to only a slight change in the serum aminogram characteristic of hepatic failure. In patients who underwent operations, tissue amino acid compositions of hepatocellular, gastric, and colon cancers were compared with each other and their respective surrounding epithelia. Amino acid contents in the tumor tissue were generally higher than those in the respective nontumorous parts, especially in the case of HCC. The methionine, tyrosine, and phenylalanine contents in HCC were much higher than in cirrhotic or normal liver. Serum aminograms in rats with ethionine-induced HCC were similar to those in cirrhotic patients with HCC. Amino acid contents in HCC were much higher than those in the surrounding cirrhotic liver tissue of rats. Serum and liver tyrosine and isoleucine contents rose significantly in rats 5 to 6 weeks after the initiation of a 0.25% ethionine-containing diet. After the 20th week of the experiment, by which time well-differentiated HCC had developed, liver tyrosine and isoleucine contents increased whereas serum isoleucine concentrations decreased. The results suggest that the serum amino acid patterns characteristic of cirrhotic patients with HCC may result from the increased consumption of amino acids by HCC. Determinations of the amino acid levels are also useful for estimating the prognosis and discovering imminent hepatic encephalopathy in cirrhotic patients with HCC.
对患有和未患有肝细胞癌(HCC)的肝硬化患者的血清氨基酸浓度进行了研究。在无恶性肿瘤的肝硬化患者中观察到的血清芳香族氨基酸(AAA)和蛋氨酸水平升高,在患有HCC的肝硬化病例中并不明显,因此在后一种情况下支链氨基酸(BCAA)与AAA的比例降低程度没有那么大。患有HCC的肝硬化患者发生肝性脑病仅导致肝功能衰竭特征性血清氨基酸谱的轻微变化。在接受手术的患者中,比较了肝细胞癌、胃癌和结肠癌组织氨基酸组成及其各自周围的上皮组织。肿瘤组织中的氨基酸含量通常高于各自的非肿瘤部分,尤其是在HCC的情况下。HCC中的蛋氨酸、酪氨酸和苯丙氨酸含量远高于肝硬化或正常肝脏。乙硫氨酸诱导的HCC大鼠的血清氨基酸谱与患有HCC的肝硬化患者相似。HCC中的氨基酸含量远高于大鼠周围的肝硬化肝组织。在开始含0.25%乙硫氨酸饮食5至6周后,大鼠血清和肝脏中的酪氨酸和异亮氨酸含量显著升高。实验第20周后,此时已发展出高分化HCC,肝脏酪氨酸和异亮氨酸含量增加,而血清异亮氨酸浓度降低。结果表明,患有HCC的肝硬化患者的血清氨基酸模式特征可能是由于HCC对氨基酸的消耗增加所致。测定氨基酸水平对于评估患有HCC的肝硬化患者的预后和发现即将发生的肝性脑病也很有用。